Bachem Holding AG BANB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CHF 71.05
- Day Range
- CHF 71.25–73.50
- 52-Week Range
- CHF 54.75–91.65
- Bid/Ask
- CHF 75.50 / CHF 74.20
- Market Cap
- CHF 5.47 Bil
- Volume/Avg
- 68,318 / 60,660
Key Statistics
- Price/Earnings (Normalized)
- 46.35
- Price/Sales
- 9.48
- Dividend Yield (Trailing)
- 1.10%
- Dividend Yield (Forward)
- 1.10%
- Total Yield
- 1.11%
Company Profile
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.
- Sector
- Basic Materials
- Industry
- Chemicals
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,009
- Website
- https://www.bachem.com
Comparables
Valuation
|
Metric
|
BANB
|
PPGN
|
BIOEE
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.35 | — | 4.49 |
Price/Book Value | 4.18 | 3.02 | 0.92 |
Price/Sales | 9.48 | 3.34 | 8.04 |
Price/Cash Flow | 18.01 | 70.61 | 22.31 |
Price/Earnings
BANB
PPGN
BIOEE
Financial Strength
|
Metric
|
BANB
|
PPGN
|
BIOEE
|
|---|---|---|---|
Quick Ratio | 1.57 | 1.09 | — |
Current Ratio | 3.41 | 1.85 | — |
Interest Coverage | 4,655.00 | −9.37 | — |
Quick Ratio
BANB
PPGN
BIOEE
Profitability
|
Metric
|
BANB
|
PPGN
|
BIOEE
|
|---|---|---|---|
Return on Assets (Normalized) | 7.25% | −4.24% | 8.82% |
Return on Equity (Normalized) | 9.18% | −7.32% | 10.04% |
Return on Invested Capital (Normalized) | 9.02% | −5.69% | — |
Return on Assets
BANB
PPGN
BIOEE
Chemicals Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Shin-Etsu Chemical Co Ltd DR
SHECY
| — | Llrnx | $86.7 Bil | |||
| Shin-Etsu Chemical Co Ltd
SHECF
| — | Kqxqcg | $86.7 Bil | |||
| Basf SE
BFFAF
| — | Qtgtsz | $48.2 Bil | |||
| Basf SE ADR
BASFY
| Cfmfnxsb | Fbzwr | $48.2 Bil | |||
| Dow Inc
DOW
| Pvsvqsc | Ykrhwp | $38.6 Bil | |||
| Nippon Sanso Holdings Corp
TYNPF
| — | Npclhww | $16.3 Bil | |||
| Celanese Corp Class A
CE
| Rdwwscyby | Hffwncc | $15.2 Bil | |||
| Asahi Kasei Corp ADR
AHKSY
| — | Gxgdg | $10.6 Bil | |||
| Asahi Kasei Corp
AHKSF
| — | Mzm | $10.6 Bil | |||
| Ganfeng Lithium Group Co Ltd ADR
GNENY
| — | Prmjnnj | $8.3 Bil |
United States